Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Reversible Inhibitors of Monoamine Oxidase

Known as: Reversible Inhibitor of Monoamine Oxidase 
RIMA shows preference for the A isoenzyme
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Methylene blue (MB) has been shown to act at multiple cellular and molecular targets and as a result possesses diverse medical… Expand
Is this relevant?
2003
2003
Befloxatone is a competitive and reversible inhibitor of monoamine oxidase-A (MAOI-A). The aim of the study was to characterize… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2001
2001
BACKGROUND Although efficacy studies suggest equal potency among antidepressant treatments, their effectiveness in clinical… Expand
Is this relevant?
2000
2000
The present investigation was conducted to examine whether a reversible inhibitor of monoamine oxidase (MAO)-A, T-794, affects… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Impaired cognitive function and enhanced activity of the hypothalamic-pituitary-adrenocortical system are among the cardinal… Expand
Is this relevant?
1994
1994
Previous results from our laboratory have indicated that small intravenous doses of the α2-adrenergic agonist Clonidine increase… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
1993
Review
1993
Brofaromine is a tight-binding, reversible inhibitor of monoamine oxidase-A (MAO-A), with concomitant serotonin (5-HT) uptake… Expand
Is this relevant?
1990
1990
The design and the main therapeutic results of 3 controlled double-blind studies comparing moclobemide with tricyclics and/or… Expand
Is this relevant?
1990
1990
Moclobemide, a new selective and reversible inhibitor of monoamine oxidase A (RIMA), has been compared with various tricyclic… Expand
Is this relevant?
1989
1989
The novel antidepressant moclobemide is a reversible inhibitor of monoamine oxidase (MAO), preferentially of type A. Moclomide… Expand
Is this relevant?